# EFFECTS OF MOXIFLOXACIN AND GEMIFLOXACIN ON BLOOD GLUCOSE AND ECG MORPHOLOGY OF EUGLYCEMICS:A CLINICAL STUDY

> **NCT04692623** · PHASE1 · COMPLETED · sponsor: **Shaheed Benazir Bhutto University Sheringal Dir Upper** · enrollment: 25 (actual)

## Conditions studied

- Blood Glucose, Low
- Hypoglycemia

## Interventions

- **DRUG:** Moxifloxacin 400mg
- **DRUG:** Gemifloxacin 320 MG

## Key facts

- **NCT ID:** NCT04692623
- **Lead sponsor:** Shaheed Benazir Bhutto University Sheringal Dir Upper
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-03-01
- **Primary completion:** 2021-03-15
- **Final completion:** 2021-04-01
- **Target enrollment:** 25 (ACTUAL)
- **Last updated:** 2023-04-12

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04692623

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04692623, "EFFECTS OF MOXIFLOXACIN AND GEMIFLOXACIN ON BLOOD GLUCOSE AND ECG MORPHOLOGY OF EUGLYCEMICS:A CLINICAL STUDY". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT04692623. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*